Medical technology company Redsense Medical reports increased revenue and profit during the second quarter. Revenue increased 12.7 percent to SEK 7.1 million (6.3).Operating profit amounted to SEK 0.4 million (-1.8), with an operating margin of 5.6 percent. Net profit amounted to SEK 0.4 million (-1.8). Earnings per share amounted to SEK 0.03 (-0.11).Redsense Medical's CEO Sebastien Bollue, writes in the report that he views the first half of the year as a sign that the stability built up during 2025 is now delivering stronger underlying development. Revenue has increased and operating profit has improved significantly. At the same time, sales of consumables point to increased use of the installed base.In the US, the focus is on increasing usage together with existing healthcare providers and reaching more clinics and patient groups. In the UK and Germany, the goal is to turn the promising work into larger and recurring commercial opportunities for Redsense Clamp.The company remains positive about the opportunities ahead and at the same time intends to maintain financial and operational discipline. The goal is to build a business that can finance its own growth, writes the Redsense Medical chief. Redsense Medical, SEK millionQ2-2026Q2-2025ChangeNet sales7.16.312.7%Operating profit0.4-1.8Operating margin5.6%Net profit0.4-1.8